Absci Corp Total Assets Over Time
| ABSI Stock | USD 3.33 0.50 13.05% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Absci Corp Performance and Absci Corp Correlation. Absci |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Absci Corp. If investors know Absci will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Absci Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.93) | Revenue Per Share 0.04 | Quarterly Revenue Growth 1.286 | Return On Assets (0.27) | Return On Equity (0.49) |
The market value of Absci Corp is measured differently than its book value, which is the value of Absci that is recorded on the company's balance sheet. Investors also form their own opinion of Absci Corp's value that differs from its market value or its book value, called intrinsic value, which is Absci Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Absci Corp's market value can be influenced by many factors that don't directly affect Absci Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Absci Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Absci Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Absci Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Assets Analysis
Compare Absci Corp and related stocks such as Recursion Pharmaceuticals, Affimed NV, and Sana Biotechnology Total Assets Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RXRX | 101.4 M | 101.4 M | 101.4 M | 101.4 M | 101.4 M | 101.4 M | 101.4 M | 101.4 M | 101.4 M | 101.4 M | 298.6 M | 610.3 M | 701.3 M | 653.7 M | 520.4 M |
| AFMD | 7.2 M | 7.2 M | 7.2 M | 6.5 M | 41.9 M | 79.3 M | 48.7 M | 43.2 M | 116.2 M | 112.4 M | 175.7 M | 225.1 M | 200.5 M | 97.2 M | 105.8 M |
| SANA | 34.3 M | 34.3 M | 34.3 M | 34.3 M | 34.3 M | 34.3 M | 34.3 M | 34.3 M | 34.3 M | 415.7 M | 730.3 M | 1.1 B | 822.7 M | 565.3 M | 677.9 M |
| RLAY | 428.6 M | 428.6 M | 428.6 M | 428.6 M | 428.6 M | 428.6 M | 428.6 M | 428.6 M | 428.6 M | 393.1 M | 799.8 M | 1 B | 1.1 B | 844 M | 838.5 M |
| ZURA | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 141.5 M | 100.8 M | 90.6 M |
| ELEV | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 80.9 M | 149.5 M | 94.2 M | 89.1 M | 91.4 M |
| HEPA | 86.7 K | 86.7 K | 86.7 K | 2 M | 2 M | 5.4 M | 13.1 M | 18.4 M | 8.2 M | 20.6 M | 48.6 M | 103.6 M | 60.2 M | 18.1 M | 27.5 M |
| CRBU | 61.9 M | 61.9 M | 61.9 M | 61.9 M | 61.9 M | 61.9 M | 61.9 M | 61.9 M | 61.9 M | 61.9 M | 36 M | 442.4 M | 373.8 M | 432.2 M | 296.2 M |
| DAWN | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 45.7 M | 289.8 M | 349.1 M | 376 M | 239.3 M |
| ABOS | 7.3 M | 7.3 M | 7.3 M | 7.3 M | 7.3 M | 7.3 M | 7.3 M | 7.3 M | 7.3 M | 7.3 M | 44.4 M | 230.3 M | 196.6 M | 310.1 M | 173.5 M |
| XFOR | 9.5 M | 9.5 M | 9.5 M | 9.5 M | 9.5 M | 9.5 M | 7.6 M | 81.3 M | 36 M | 160.7 M | 122.9 M | 117.2 M | 155.6 M | 147.3 M | 102.4 M |
| INZY | 43.5 M | 43.5 M | 43.5 M | 43.5 M | 43.5 M | 43.5 M | 43.5 M | 43.5 M | 43.5 M | 47.9 M | 169.4 M | 123.5 M | 139.2 M | 200.8 M | 132.8 M |
Absci Corp and related stocks such as Recursion Pharmaceuticals, Affimed NV, and Sana Biotechnology Total Assets description
Total assets refers to the total amount of Absci Corp assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Absci Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.My Equities
My Current Equities and Potential Positions
| Absci Corp | ABSI |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Washington; U.S.A |
| Exchange | NASDAQ Exchange |
USD 3.33
Check out Absci Corp Performance and Absci Corp Correlation. For more detail on how to invest in Absci Stock please use our How to Invest in Absci Corp guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Absci Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.